DOLOMITE EPPICC Study: Pregnancy and Neonatal Outcomes following Prenatal Exposure to Dolutegravir: Data from the European Pregnancy and Paediatric HIV Cohort Collaboration (EPPICC) (208613)

First published 07/03/2018

Last updated 02/07/2024

EU PAS number:

EUPAS22915

Study

Finalised

Documents

Study protocol

Initial protocol

viiv-208613-protocol-redact

English (598.86 KB - PDF)View document

Study results

Study Report DOLOMITE EPPIC_Pregnancy_Final Report Anonymized 03 Nov 2023

English (1.87 MB - PDF)View document

Study report

Other information

ENCePP Seal

ENCePP Seal documents

Secondary tabs